Die aktuellsten Nachrichten von Arznei-News zu den Krebsmedikamenten finden Sie unter dem jeweiligen Medikament oder insgesamt unter: News aus der Forschung zu Medikamenten gegen Krebs.
Liste der Krebsmedikamente
- 5-Fluorouracil
- Abemaciclib (Verzenios)
- Abirateronacetat
- Abirateron (Zytiga)
- Acalabrutinib
- Adagrasib
- Afatinib (GIOTRIF)
- Afinitor
- Aflibercept (Eylea, Zaltrap)
- Alectinib (Alecensa)
- Alemtuzumab (Lemtrada)
- Aldoxorubicin
- Alpelisib (Piqray)
- Amatuximab
- Amivantamab
- Anastrozol
- Apalutamid
- Apatorsen
- Apealea
- Arfolitixorin
- Arsentrioxid (Trisenox)
- Asciminib
- Asparaginase (Spectrila)
- Atezolizumab (Tecentriq)
- Atrasentan
- Avapritinib
- Avelumab
- Axicabtagen-Ciloleucel
- Axitinib (Inlyta)
- Azacitidin (Vidaza)
- Azedra
- Belantamab-Mafodotin
- Belinostat (Beleodaq)
- Belzutifan
- Bemarituzumab
- Bemcentinib
- Bempegaldesleukin
- Binimetinib
- Blinatumomab (Blincyto)
- Blitzima, Ritemvia, Tuxella
- Bortezomib (Velcade)
- Bosutinib (Bosulif)
- Brentuximab (Adcetris)
- Brexucabtagen Autoleucel
- Brigatinib
- Brontictuzumab
- Buparlisib
- Cabometyx
- Cabozantinib (Cometriq)
- Calaspargase Pegol (Cal-PEG)
- Cannabidiol (Epidiolex)
- Cannabinoide gegen Krebs
- Cannabis / Marihuana bei Krebs
- Capecitabin (Xeloda)
- Capivasertib
- Capmatinib
- Carboplatin (Carbomedac)
- Carfilzomib (Kyprolis)
- Carmubris (Carmustin)
- Cemiplimab (Libtayo)
- Ceritinib (Zykadia)
- Cetuximab (Erbitux)
- Chlormethin (Ledaga)
- Cirmtuzumab
- Cisplatin
- Cladribin
- Cobimetinib (Cotellic)
- Copanlisib
- Crizotinib (Xalkori)
- Dabrafenib (Tafinlar)
- Dacarbazin
- Dacomitinib (Vizimpro)
- Daratumumab (Darzalex)
- Darolutamid
- Dasatinib (Sprycel)
- Datopotamab
- Decitabin
- Devimistat
- Dinutuximab (Unituxin)
- Docetaxel (Taxotere)
- Dostarlimab
- Doxorubicin-Transdrug (Livatag)
- Durvalumab
- Duvelisib (Copiktra)
- Eganelisib
- Eldisine
- Elotuzumab (Empliciti)
- Elranatamab
- Enadenotucirev
- Enasidenib
- Encorafenib (Braftovi)
- Enfortumab
- Enobosarm
- Ensartinib
- Entinostat
- Entrectinib
- Enzalutamid (Xtandi)
- Epacadostat
- Eprenetapopt
- Erbitux (Cetuximab)
- Erdafitinib
- Eribulin (Halaven)
- Erivedge (Vismodegib)
- Erleada
- Erlotinib (Tarceva)
- Eryaspase (Graspa)
- Everolimus
- Fexapotid
- Fruquintinib
- Glivec
- Gefitinib (Iressa)
- Gemcitabin (Gemzar)
- Gemtuzumab-Ozogamicin (Mylotarg)
- Gilteritinib
- Giredestrant
- Glembatumumab vedotin
- Glasdegib
- Glofitamab
- Guadecitabin
- Hemangiol
- Herceptin
- Hyleukin-7
- Ibrutinib (Imbruvica)
- Iclusig
- Idecabtagen Vicleucel (Ide-cel)
- Idelalisib (Zydelig)
- Idronoxil
- Ilixadencel
- Imatinib
- Infigratinib
- Inotuzumab ozogamicin
- Ipatasertib
- Ipilimumab (Yervoy)
- Irinotecan (Onivyde)
- Ivosidenib
- Kadcyla
- Kisplyx
- Glivec
- Opaganib
- Inotuzumab-Ozogamicin (Besponsa)
- Iobenguan (Azedra)
- Isatuximab
- Kanjinti
- Lanreotid (Somatulina)
- Lapatinib (Tyverb)
- Larotrectinib
- Lenalidomid (Revlimid)
- Lenvatinib (Lenvima)
- Letrozol (Femara)
- Lirilumab
- Liso-cel / Lisocabtagen maraleucel
- Lomustin (Cecenu)
- Lonsurf
- Lorbrena
- Lorlatinib
- Lorviqua
- Lu-PSMA-617
- Lurbinectedin
- Lu-177 (Lutathera)
- Lymphoseek
- Margetuximab
- Masitinib
- Masiviera
- Melphalan (Alkeran, Evomela)
- Methadon
- Midostaurin
- Milciclib
- Mirdametinib
- Mirvetuximab-Soravtansin
- Mobocertinib
- Motixafortid
- Moxetumomab Pasudotox (Lumoxiti)
- Mvasi
- Nab-Paclitaxel
- Nadofaragen Firadenovec
- Naxitamab
- Necitumumab (Portrazza)
- Nelipepimut-S (NeuVax)
- Neratinib (Nerlynx)
- Nexavar
- Nidanilimab
- Nilotinib (Tasigna)
- Nimotuzumab
- Nintedanib (Vargatef)
- Niraparib
- Nivolumab (Opdivo)
- Obinutuzumab (Gazyvaro)
- Ofatumumab (ARZERRA)
- Olaparib (Lynparza)
- Olaratumab (Lartruvo)
- Olmutinib
- Omacetaxin (Synribo)
- Ontruzant
- Osimertinib (Tagrisso)
- Paclitaxel (Abraxane)
- Padeliporfin (Tookad)
- Palbociclib (Ibrance)
- Panitumumab (Vectibix)
- Panobinostat (Farydak)
- Pasotuxizumab
- Patritumab
- Pegaspargase (Oncaspar)
- Pegilodecakin
- Pelareorep
- Pembrolizumab (Keytruda)
- Pemetrexed (Alimta)
- Pemigatinib
- PERJETA
- Pertuzumab
- Pevonedistat
- Pexidartinib
- Pexa-Vec (Pexastimogene devacirepvec)
- Pixantron (Pixuvri)
- Pirtobrutinib
- Plitidepsin (Aplidin)
- Polatuzumab Vedotin
- Ponatinib
- Poziotinib
- Pralsetinib
- Propranolol
- Proscar
- Proxalutamid
- Quisinostat
- Quizartinib
- Ramucirumab (Cyramza)
- Rebastinib
- Regorafenib (Stivarga)
- Relatlimab
- Remetinostat
- Ribociclib
- Ridaforolimus (Jenzyl)
- Rindopepimut (Rintega)
- Ripretinib
- Rixathon
- Rociletinib
- Rovalpituzumab-Tesirin (Rova-T)
- Rucaparib
- Ruxolitinib (Jakavi, Jakafi)
- Sacituzumab-Govitecan
- Saposin C
- Savolitinib
- Selpercatinib
- Selumetinib
- Seviteronel
- Siltuximab (Sylvant)
- Sintilimab
- Sipuleucel-T (Provenge)
- Sonidegib (Odomzo)
- Sorafenib
- Sotorasib
- Sulfatinib
- Sunitinib (Sutent)
- Surufatinib
- Tafasitamab
- Talazoparib
- Talimogen Laherparepvec (Imlygic)
- Talzenna
- Tamoxifen (Nolvadex)
- Tarextumab
- Taselisib
- Tazemetostat
- Tebentafusp
- Teclistamab
- Telisotuzumab
- Temozolomid
- Tepotinib
- Tesetaxel
- Tilsotolimod
- Tiragolumab
- Tisagenlecleucel-T
- Tislelizumab
- Tisotumab Vedotin
- Tivantinib
- Tivozanib
- Topotecan (Hycamtin)
- Trabectedin (Yondelis)
- Trametinib (Mekinist)
- Trastuzumab
- Trazimera
- Trebananib
- Tremelimumab
- Treosulfan (Trecondi)
- Tucatinib
- Ulixertinib
- Uridin Triacetat (Vistogard)
- Umbralisib
- Uproleselan
- Vandetanib
- Veliparib
- Vemurafenib (Zelboraf)
- Venetoclax
- Vicinium
- Vintafolid (Vynfinit)
- Vistusertib
- Vitrakvi
- Volasertib
- Vorinostat
- Vosaroxin (QINPREZO)
- Votubia
- Vyxeos
- Xagrid
- Xgeva
- Xofigo
- Xeloda
- Zanubrutinib
- Zanidatamab
- Zirabev